Small Business Resources, Business Advice and Forms from AllBusiness.com

AstraZeneca Will Pay $355 Million to Settle Drug Fraud Charges.

By Alice Dembner, The Boston Globe Knight Ridder/Tribune Business News

Jun. 21--Drug maker AstraZeneca agreed to the second largest settlement for alleged drug fraud in US history yesterday, paying $355 million to resolve criminal and civil allegations that the company inflated the price of its prostate cancer drug and bribed doctors to prescribe it.

The settlement, announced by federal prosecutors in Delaware, is second only to the record $885 million paid by TAP Pharmaceutical Products in 2001 to settle similar allegations in a Boston case. During th

In addition, make sure to read these premium articles also available with your free trial:

T T T
art_print Printart_email Email 16x16-digg-guy  Digg It delicious-small  del.icio.us

Related Resources

Free AllBusiness Articles

  • TAP Pharmaceuticals settles with DOJ for $875 million
    • UPDATA TAP Pharmaceutical Products has agreed to pay the government a record $875 million to settle extensive civil and criminal charges of illegally marketing and manipulating the costs of Lupron, a prostate cancer drug, under the Medicare and Medicaid programs, the Department of Justice (DOJ) announced October 3, 2001. The......
  • Tenet's troubles.
    • TENET HEALTHCARE CORPORATION, the second largest U.S. hospital chain, will pay almost a billion dollars to settle fraud claims. Under a June agreement with the U.S. Department of Justice, Tenet will pay a total of $900 million over a four-year period, plus interest, to resolve various types of civil allegations ......
  • Using litigation to regulate drug prices: The assault on AWP
    • HEADNOTE A "sleeper" issue hangs over the Rx industry. The TAP/Lupron settlement with the government opened up the contentious subject of "average wholesale price" (AWP) - the actual cost of Medicare Part B drugs to providers and what they charge Medicare and other insurance carriers. With lawsuits on the horizon, ......
  • TAP Pharmaceuticals settles with DOJ for $875 million. (Updata).
    • TAP Pharmaceutical Products has agreed to pay the government a record $875 million to settle extensive civil and criminal charges of illegally marketing and manipulating the costs of Lupron, a prostate cancer drug, under the Medicare and Medicaid programs, the Department of Justice (DOJ) announced October 3, 2001. The amount ......
  • Watson and Unimed settle lawsuit over testosterone gel.
    • Watson Pharmaceuticals, Inc. (Corona, CA), a leading specialty pharmaceutical company, announced that it has reached a settlement with Unimed Pharmaceuticals, Inc., a wholly owned subsidiary of Solvay Pharmaceuticals, Inc., and Laboratories Besins Iscovesco on outstanding patent litigation related to AndroGel 1% (testosterone gel) CIII, a topical testosterone replacement gel. In ......
  • PhRMA chief urges industry to make Medicare work
    • ALAN HOLMER, speaking at the Pharmaceutical Research and Manufacturers of America (PhRMA) annual meeting last month, defended the new Medicare prescription drug coverage as a "meaningful benefit," but warned the industry that one of its key tenets, free-market pricing, is in jeopardy. Holmer, who announced his plan to retire as ......
  • North: Hospital Settles Fraud Charges
    • PHILUPSBURG Warren Hospital has agreed to pay the United States $7.5 million to settle allegations of Medicare fraud, according to U.S. Attorney Christopher J. Christie. Two whistleblower lawsuits brought by individuals on behalf of the federal government had accused Warren Hospital of improperly inflating charges to Medicare patients to obtain ......

Blogs

  • 47 traders face fraud charges
    • 47 traders face fraud charges (November 20, 2003) : "47 traders face fraud charges" "US federal prosecutors today filed charges against 47 traders in the foreign exchange market, after an FBI undercover operation exposed a murky world of fraud, corruption and narcotics trafficking." - This is greed, pure and ......
  • Should Balance Billing Be Allowed?
    • Reimbursement is flat, and we want to reward quality. So should balance billing be allowed to reflect supply and demand?
  • Work From Home vs Home-Based Business
    • There are two general categories of work-from-home arrangements. On one hand, you have an actual business that you start and build yourself from home. On the other hand there are arrangements where you supposedly work for someone else (from home). The idea of stuffing envelopes, mailing forms, or performing some ......
  • All Bloggers
Related Topics
Tools

Sponsored Links

Site Map | Contact Us | FAQs | About Us | Media Kit | Reprints | RSS Directory | Sign Up for Free Newsletters | Disclosure Policy

Copyright © 1999 - 2008 AllBusiness.com, Inc. All rights reserved.
No part of this content or the data or information included therein may be reproduced,
republished or redistributed without the prior written consent of AllBusiness.com.
Use of this site is governed by our Copyright and Intellectual Property Policy, Terms of Use Agreement and Privacy Policy.

Get In-Depth Company Information from Hoover's | Buy a D&B Credit Report | What is in Your Company's D&B Credit Report? | Article Archives
Online Business Database | Online Business Information | Sales and Marketing Solutions | Business Mailing Lists
Information and opinions on AllBusiness.com solely represent the thoughts and opinions of the authors and are not endorsed by, or reflect the beliefs of,
AllBusiness.com, its parent company D&B, and its affiliates.